留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x 关闭 永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

新型喜树碱纳米凝胶给药系统的构建及体外透皮特性研究

王翔,  张梁宇,  丁宝月,  陈杨

downloadPDF
文章导航 > 药学实践与服务  > 2016 >  34(2): 148-152
王翔, 张梁宇, 丁宝月, 陈杨. 新型喜树碱纳米凝胶给药系统的构建及体外透皮特性研究[J]. 药学实践与服务, 2016, 34(2): 148-152. doi: 10.3969/j.issn.1006-0111.2016.02.013
引用本文: 王翔, 张梁宇, 丁宝月, 陈杨. 新型喜树碱纳米凝胶给药系统的构建及体外透皮特性研究[J]. 药学实践与服务, 2016, 34(2): 148-152. doi: 10.3969/j.issn.1006-0111.2016.02.013
shu
WANG Xiang, ZHANG Liangyu, DING Baoyue, CHEN Yang. Novel camptothecin loaded nanogel system: formulation optimization and in vitro transdermal permeability study[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(2): 148-152. doi: 10.3969/j.issn.1006-0111.2016.02.013
Citation: WANG Xiang, ZHANG Liangyu, DING Baoyue, CHEN Yang. Novel camptothecin loaded nanogel system: formulation optimization and in vitro transdermal permeability study[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(2): 148-152. doi: 10.3969/j.issn.1006-0111.2016.02.013
shu

新型喜树碱纳米凝胶给药系统的构建及体外透皮特性研究

doi: 10.3969/j.issn.1006-0111.2016.02.013
  • 1.

    解放军98医院, 浙江 湖州 313000

  • 2.

    嘉兴学院医学院, 浙江 嘉兴 314001

基金项目: 国家自然科学基金(81201809);南京军区科技创新重点项目(12Z03);全军医学科技青年培育项目(13QNP045)

Novel camptothecin loaded nanogel system: formulation optimization and in vitro transdermal permeability study

  • 1.

    No.98 Hospital of PLA, Huzhou 313000, China

  • 2.

    School of Medicine, Jiaxing College, Jiaxing 310014, China

  • 摘要: 目的 制备新型喜树碱纳米凝胶给药系统(CPT-PPO gel),并对其含量、理化性质和体外透皮特性进行考察。 方法 以乙交酯-丙交酯共聚物(PLGA)包裹抗银屑病药物喜树碱(CPT)作为纳米系统的核,将聚酰胺-胺(PAMAM,G3.0)包裹在PLGA表面作为纳米系统的壳,采用乳化溶剂挥发法制备载喜树碱纳米系统(CPT-PLGA-PAMAM, CPT-PP),并用油酸(OA)进行修饰,得到经表面改性的核壳纳米给药系统(CPT-PLGA-PAMAM-OA, CPT-PPO)。采用HPLC法测定纳米乳中喜树碱的含量,采用透射电镜和激光粒径测定仪分别考察纳米粒的形态和粒径。以羟丙甲基纤维素(HPMC)为基质,制备CPT-PPO gel,并采用Franz扩散池对其体外透皮特性进行考察。 结果 制得的CPT-PPO gel平均粒径为(246.7±5.4) nm,包封率为(78.7±6.9)%,含量稳定,在4℃时具有良好的稳定性。体外透皮实验表明,纳米凝胶CPT-PPO gel、CPT-PP gel比普通凝胶CPT gel有更高的皮肤渗透量和滞留量(P<0.01),且CPT-PPO gel在皮肤渗透量和滞留量上均显著高于CPT-PP gel(P<0.05)。 结论 经过OA修饰的CPT-PPO gel可以显著提高药物的皮肤吸收量和滞留量,有望成为应用CPT局部治疗银屑病的新剂型。
    Abstract: Objective To prepare a novel drug delivery system camptothecin loaded nanogel(CPT-PPO gel), and investigate its contents, physical and chemical properties and in vitro transdermal permeability. Methods The solvent evaporation method was utilized to prepare core-shell nano-drug delivery systems(CPT-PLGA-PAMAM, CPT-PP), in which the Poly lactic-co-glycolic acid(PLGA) was used to load camptothecin as the nucleus and the polyamidoamine(PAMAM) G3.0 was wrapped in the surface of PLGA as the shell. Then the oleic acid(OA) was connected to CPT-PP to obtain the surface modified drug delivery system(CPT-PLGA-PAMAM OA, CPT-PPO). HPLC was used to determine the content of camptothecin in nanoparticles, transmission electron microscopy was applied to identify the nanoparticles morphology, and laser analyzer was used to determine the particle size. The hydroxypropyl methylcellulose(HPMC) was added as the base for the preparation of the nanogel(CPT-PPO gel) at last. The Franz-diffusion cell was used to determine the permeation rate of nanogel in vitro. Results The resulting CPT-PPO gel was stable at 4℃, the average particle size was(246.7±5.4) nm and the encapsulation efficiency was up to(78.7±6.9)%. Comparing to the normal gel,(CPT gel), the cumulative penetration amount and the retention amount in the skin of the nanogels(CPT-PPO gel,CPT-PP gel) were significant higher(P<0.01), the retention and cumulative penetration amount of CPT-PPO gel was significant higher than that of CPT-PP gel(P<0.05). Conclusion After modified by OA, CPT-PPO gel can increase the cumulated amount and absorption in skin and can be used as a carrier of CPT in the new formulation for topical treatment of psoriasis.
  • [1] Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery[J]. Eur J Pharm Sci, 2001, 14(2):101-114.
    [2] Prow TW, Grice JE, Lin LL, et al. Nanoparticles and microparticles for skin drug delivery[J]. Adv Drug Deliv Rev, 2011, 63(6):470-491.
    [3] Gupta M, Vyas SP. Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis[J]. Chem Phys Lipids, 2012, 165(4):454-461.
    [4] Bachhav YG, Mondon K, Kalia YN, et al. Novel micelle formulations to increase cutaneous bioavailability of azole antifungals[J]. J Control Release, 2011, 153(2):126-132.
    [5] Vijayan V, Reddy KR, Sakthivel S, et al. Optimization and charaterization of repaglinide biodegradable polymeric nanoparticle loaded transdermal patchs:in vitro and in vivo studies[J]. Colloids Surf B Biointerfaces, 2013, 1(111):150-155.
    [6] Agrawal U, Mehra NK, Gupta U et al. Hyperbranched dendritic nano-carriers for topical delivery of dithranol[J]. J Drug Target,2013, 21(5):497-506.
    [7] Chen Y, Wang M, Fang L. Biomaterials as novel penetration enhancers for transdermal and dermal drug delivery systems[J]. Drug Deliv, 2013, 20(5):199-209.
    [8] Rancan F, Papakostas D, Hadam S, et al. Investigation of polylactic acid(PLA) nanoparticles as drug delivery systems for local dermatotherapy[J]. Pharm Res, 2009, 26(8):2027-2036.
    [9] Shah PP, Desai PR, Channer D, et al. Enhanced skin permeation using polyarginine modified nanostructured lipid carriers[J]. J Controlled Release, 2012, 161(3):735-745.
    [10] Shah PP, Desai PR, Patel AR, et al. Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs[J]. Biomaterials, 2012, 33(5):1607-1617.
    [11] Yang Y, Sunoqrot S, Stowell C, et al. Effect of size, surface charges, and hydrophobicity of poly(amidoamine) dendrimers on their skin penetration[J]. Biomacromolecules,2012, 13(7):2154-2162.
    [12] O'Leary J, Muggia FM. Camptothecins:a review of their development and schedules of administration[J]. Eur J Cancer, 1998,34(10):1500-1508.
    [13] Min KH, Park K, Kim YS, et al. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy[J]. J Control Release,2008, 127(3):208-218.
    [14] Andrew J. Jennifer K. Carmen J, et al. Convection-enhanced delivery of camptothecin-loaded polymer nanoparticles for treatment of intracranial tumors[J]. Drug Deliv Transl Res,2011,1(1):34-42.
    [15] Castillo PM, de la Mata M, Casula MF, et al. PEGylated versus non-PEGylated magnetic nanoparticles as camptothecin delivery system[J]. Beilstein J Nanotechnol, 2014, 5:1312-1319.
    [16] Zhang L, Hu Y, Jiang X, et al. Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice[J]. J Control Release, 2004, 96(1):135-148.
    [17] Botella P, Abasolo I, Fern ndez Y, et al. Surface-modified silica nanoparticles for tumor-targeted delivery of camptothecin and its biological evaluation[J].J Control Release,2011,156(2):246-257.
  • [1] 张艺昕, 关欣怡, 王博宁, 闻俊, 洪战英.  二氢吡啶类钙离子拮抗药物手性分析及其立体选择性药动学研究进展 . 药学实践与服务, 2024, 42(8): 319-324. doi: 10.12206/j.issn.2097-2024.202308062
    [2] 崔亚玲, 吴琼, 马良煜, 胡北, 姚东, 许子华.  肝素钠肌醇烟酸酯乳膏中肌醇烟酸酯皮肤药动学研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202404006
    [3] 陈炳辰, 佟达丰, 万苗, 闫飞虎, 姚建忠.  UPLC-MS/MS法测定小鼠血浆中紫杉醇脂肪酸酯前药及其药代动力学研究 . 药学实践与服务, 2024, 42(8): 341-345. doi: 10.12206/j.issn.2097-2024.202404082
    [4] 陈怡君, 王卓, 何苗, 张宇, 田泾.  泌尿系统碎石术抗菌药物预防使用合理管控实践 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202402034
    [5] 张广雨, 杜晶, 刘梦珍, 朱丹妮, 闫慧, 刘冲.  新斯的明与山莨菪碱联合应用对肺型氧中毒的保护作用及其机制的研究 . 药学实践与服务, 2024, 42(10): 433-438, 444. doi: 10.12206/j.issn.2097-2024.202310049
    [6] 郭灵怡, 刘艳超, 高路, 刘瑞瑶, 吕权真, 俞媛.  醋酸卡泊芬净单硬脂酸甘油酯纳米粒抗白色念珠菌感染的增效作用研究 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202310043
    [7] 迟文雅, 袁艳, 李伟林, 吴茼妤, 俞媛.  负载骨髓间充质干细胞/白藜芦醇脂质体的水凝胶支架用于创伤性脑损伤治疗 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202406034
    [8] 邹思, 吴岩斌, 吴锦忠, 吴建国, 黄家兴.  虎奶菇菌核多糖功能化纳米硒抗疲劳功效研究 . 药学实践与服务, 2024, 42(10): 426-432. doi: 10.12206/j.issn.2097-2024.202206072
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  3548
  • HTML全文浏览量:  348
  • PDF下载量:  28
  • 被引次数: 0
出版历程
  • 收稿日期:  2015-03-09
  • 修回日期:  2016-01-12

新型喜树碱纳米凝胶给药系统的构建及体外透皮特性研究

doi: 10.3969/j.issn.1006-0111.2016.02.013
  • 1. 解放军98医院, 浙江 湖州 313000
  • 2. 嘉兴学院医学院, 浙江 嘉兴 314001
    • 基金项目:  国家自然科学基金(81201809);南京军区科技创新重点项目(12Z03);全军医学科技青年培育项目(13QNP045)
  • 收稿日期: 2015-03-09
  • 修回日期: 2016-01-12

摘要: 目的 制备新型喜树碱纳米凝胶给药系统(CPT-PPO gel),并对其含量、理化性质和体外透皮特性进行考察。 方法 以乙交酯-丙交酯共聚物(PLGA)包裹抗银屑病药物喜树碱(CPT)作为纳米系统的核,将聚酰胺-胺(PAMAM,G3.0)包裹在PLGA表面作为纳米系统的壳,采用乳化溶剂挥发法制备载喜树碱纳米系统(CPT-PLGA-PAMAM, CPT-PP),并用油酸(OA)进行修饰,得到经表面改性的核壳纳米给药系统(CPT-PLGA-PAMAM-OA, CPT-PPO)。采用HPLC法测定纳米乳中喜树碱的含量,采用透射电镜和激光粒径测定仪分别考察纳米粒的形态和粒径。以羟丙甲基纤维素(HPMC)为基质,制备CPT-PPO gel,并采用Franz扩散池对其体外透皮特性进行考察。 结果 制得的CPT-PPO gel平均粒径为(246.7±5.4) nm,包封率为(78.7±6.9)%,含量稳定,在4℃时具有良好的稳定性。体外透皮实验表明,纳米凝胶CPT-PPO gel、CPT-PP gel比普通凝胶CPT gel有更高的皮肤渗透量和滞留量(P<0.01),且CPT-PPO gel在皮肤渗透量和滞留量上均显著高于CPT-PP gel(P<0.05)。 结论 经过OA修饰的CPT-PPO gel可以显著提高药物的皮肤吸收量和滞留量,有望成为应用CPT局部治疗银屑病的新剂型。

English Abstract

王翔, 张梁宇, 丁宝月, 陈杨. 新型喜树碱纳米凝胶给药系统的构建及体外透皮特性研究[J]. 药学实践与服务, 2016, 34(2): 148-152. doi: 10.3969/j.issn.1006-0111.2016.02.013
引用本文: 王翔, 张梁宇, 丁宝月, 陈杨. 新型喜树碱纳米凝胶给药系统的构建及体外透皮特性研究[J]. 药学实践与服务, 2016, 34(2): 148-152. doi: 10.3969/j.issn.1006-0111.2016.02.013
shu
WANG Xiang, ZHANG Liangyu, DING Baoyue, CHEN Yang. Novel camptothecin loaded nanogel system: formulation optimization and in vitro transdermal permeability study[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(2): 148-152. doi: 10.3969/j.issn.1006-0111.2016.02.013
Citation: WANG Xiang, ZHANG Liangyu, DING Baoyue, CHEN Yang. Novel camptothecin loaded nanogel system: formulation optimization and in vitro transdermal permeability study[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(2): 148-152. doi: 10.3969/j.issn.1006-0111.2016.02.013
shu

    全文HTML

参考文献 (17)

目录

    /

    返回文章
    返回

    版权所有：《药学实践与服务》编辑委员会

    主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

    电话: （021）81871324,81871397 E-mail: [email protected]

    网站备案号 沪ICP备05003363号-1

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计